Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Association of clinical severity of cystic fibrosis with variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1 and SLC9A3)

Full text
Author(s):
Pereira, Stephanie Villa-Nova [1] ; Ribeiro, Jose Dirceu [2, 3] ; Bertuzzo, Carmen Silvia [1] ; Lima Marson, Fernando Augusto [2, 3, 1]
Total Authors: 4
Affiliation:
[1] Univ Estadual Campinas, Fac Med Sci, Dept Med Genet, Tessalia Vieira de Camargo, 126, Barao Geraldo, BR-13083887 Campinas, SP - Brazil
[2] Univ Estadual Campinas, Fac Med Sci, Dept Pediat, Tessalia Vieira de Camargo, 126, Barao Geraldo, BR-13083887 Campinas, SP - Brazil
[3] Univ Estadual Campinas, Fac Med Sci, Ctr Pediat Invest, Lab Pulm Physiol, Tessalia Vieira de Camargo, 126, Barao Geraldo, BR-13083887 Campinas, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: Gene; v. 629, p. 117-126, SEP 20 2017.
Web of Science Citations: 16
Abstract

Introduction: Cystic fibrosis (CF) manifests with clinical and histopathological variability depending on environmental and genetic factors. Moreover, the genes encoding ion channels{[}rs3788766(SLC6A/4), rs7512462(SLC26A9), rs17235416(SLC11A1) and rs17563161(SLC9A3)] have been insufficiently studied as modifier genes. Then, our objective was associate the variants in the genes of SLC family with 43 CF severity markers. Methods: The variants were identified by real-time-PCR in 188 CF patients considering the CFTR genotype. Statistical analyses were performed by parametric and nonparametric tests. The correction by multiple testing was performed by the False Rate Discovery test, alpha = 0.05. Results: Depending on the CFTR mutations, we found association of: (i) rs3788766{*}CC with mucoid Pseudomonas aeruginosa (OR = 0.171; 95%Cl = 0.029-0.696), non-mucoid P. aeruginosa (OR = 0.283; 95%CI = 0.094-0.853) and Staphyloccocus aureus (OR = 4.443; 95%Cl = 1.019-40.64), largest FEFmax(p = 0.041) and best response to bronchodilator for FEE50%(P = 0.033) and FEV1/FVC(p = 0.044); (ii) rs3788766{*}CT with early start of pulmonary symptom (OR = 3.524; 95%CI = 1.229-10.1) and osteoporosis (OR = 0.203; 95%CI = 0.022-0.883); (iii) rs3788766{*}TT with lowest body mass index (OR = 4.242; 95%CI = 1.505-11.95), presence of mucoid P. aeruginosa (OR = 3.176; 95%CI = 1.29-7.819) and S. aureus (OR = 0.116; 95%CI = 0.004-0.881), highest Bhalla score (p = 0.047) and lowest FEFmax(p = 0.028) and FEF25%(P = 0.031) values; (iv) rs7512462{*}CC with highest Shwachman-Kulczycki score (p = 0.019), FVC(p = 0.043), FEV1(p = 0.047), FEV1/FVC(p = 0.022), FEF50%(P = 0.038) and FEF25-754P = 0.016); (v) rs7512462{*}CT with lowest values of FVC(p = 0.034), FEV1(p = 0.047), FEV1/FVC(p = 0.022), FEF25%(p = 0.012), FEF50%(P = 0.038), FEF75%(P = 0.008), FEF25-75%(p = 0.016) and ERV(p = 0.023); (vi) rs7512462{*}TT with best response to the inhaled bronchodilator for FEV1(p = 0.011), FEE50%(P = 0.019), FEF75%(p = 0.036) and FEF25-75%(P = 0.008); (vii) rs17234516{*}Normal allele with lowest value of SaO(2) (p = 0.010) and S. aureus (OR = 3.333; 95%Cl = 1.085-10.24); (viii) rs17563161{*}GG with lowest age for onset of digestive symptoms (OR = 2.564; 95%CI = 1.234-5.33). Conclusions: The clinical and laboratory variability of CF were associated with the variants in the genes of SLC family in our sample. (AU)

FAPESP's process: 11/12939-4 - Association between polymorphisms in modifier genes in children and adolescent with allergic and non-allergic: mild, moderate and severe asthma
Grantee:Fernando Augusto de Lima Marson
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 15/12183-8 - Identification of prevalent mutations and clinical and functional characterization of children and adults with primary ciliary dyskinesia
Grantee:Jose Dirceu Ribeiro
Support Opportunities: Regular Research Grants
FAPESP's process: 11/18845-1 - Association between polymorphisms in modifier genes in children and adolescent with allergic and non-allergic mild, moderate and severe asthma
Grantee:Jose Dirceu Ribeiro
Support Opportunities: Regular Research Grants
FAPESP's process: 15/12858-5 - Identification of prevalent mutations and clinical and functional characterization of children and adults with primary ciliary dyskinesia
Grantee:Fernando Augusto de Lima Marson
Support Opportunities: Scholarships in Brazil - Post-Doctoral